TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push [Yahoo! Finance]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
National OCS Program (NOP) —operating 18 hubs, a 50+ surgeon network and managing nearly 30% of U.S. volume, and is pursuing membership in the federal transplant ecosystem (OPTN) with regulatory decisions likely in On clinical trials, the company says it will take “full control” of the control arm in the randomized ENHANCE study after competitor-driven friction, with Part A on track and both ENHANCE and a De Novo lung program progressing in dialogue with the FDA. TransMedics expects its kidney program could become its largest and is actively evaluating simultaneous U.S. and Europe clinical trial launches, with a more detailed protocol expected by the Q3 earnings call. Interested in TransMedics Group, Inc.? Here are five stocks we like better. Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May TransMedics Group (NASDAQ:TMDX) CEO Waleed Hassanein and CFO Gerardo Hernandez-Omana provided updates on the company's strategy, clinical trial planning, and operational init
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- Organ Preservation Market Size to Reach USD 547.41 Million by 2035; Rising Transplant Procedures and Advances in Preservation Technologies Driving Market Growth – SNS Insider [Yahoo! Finance]Yahoo! Finance
- TransMedics Group (TMDX) had its "buy" rating reaffirmed by TD Cowen.MarketBeat
- Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- Analysts Raise TransMedics Group, Inc. (TMDX) Price Targets After Q4 Results [Yahoo! Finance]Yahoo! Finance
- TransMedics Group (TMDX) had its price target raised by Stifel Nicolaus from $115.00 to $130.00. They now have a "hold" rating on the stock.MarketBeat
TMDX
Earnings
- 2/24/26 - Beat
TMDX
Sec Filings
- 3/13/26 - Form 3
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- TMDX's page on the SEC website